Santa Ana Bio
Alameda, US · Founded 2020 · Delaware corporation · 5 known investors
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
Founders & leadership
PE
Peter EmtageinFounder & CEO
AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GL
Graham LordScientific Founder
AS
Ansuman SatpathyScientific Founder
TW
Thomas WoiwodeDirector
JD
Jerel DavisinExecutive Officer, Director
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$20MraisedJun 2024 · 10 investors · BiotechnologyRule 506(b)
▶$20MraisedJun 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mittie DoyleDirector
- Peter EmtageExecutive Officer, Director
- Jerel DavisDirector
- Shinichiro FuseDirector
- Brendan Bulik-SullivanDirector
- Christine BorowskiDirector
- Marcelo BigaloDirector
- Offering amount
- $125M
- Amount sold
- $20M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$35.3MraisedFeb 2023 · 5 investors · BiotechnologyRule 506(b)
▶$35.3MraisedFeb 2023 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shinichiro FuseDirector
- Thomas WoiwodeDirector
- Brendan Bulik-SullivanDirector
- Jerel DavisDirector
- Peter EmtageExecutive Officer, Director
- Offering amount
- $70.3M
- Amount sold
- $35.3M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8MraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
▶$8MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas WoiwodeDirector
- Peter EmtageExecutive Officer, Director
- Jerel DavisExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $8M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Santa Ana Bio emerges from stealth with $168mbioprocessintl.com · 2024
- Santa Ana Bio Raises $168M in Fundingfinsmes.com · 2024
- Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases - BioSpacebiospace.com · 2024
- Santa Ana Bio Launches With $168 Million to Advance Precision Medicines for Inflammatory Diseases - BioSpacebiospace.com · 2024